Log in to save to my catalogue

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b951ed84b334332afdc952be95c34f9

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

About this item

Full title

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

Publisher

England: BioMed Central

Journal title

Respiratory research, 2017-04, Vol.18 (1), p.74-74, Article 74

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by an unpredictable course. Prognostic markers and disease activity markers are needed. The purpose of this single-center retrospective study was to evaluate the prognostic value of lung fluorodeoxyglucose ([
F]-FDG) uptake assessed by standardized uptake value (SUV), met...

Alternative Titles

Full title

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b951ed84b334332afdc952be95c34f9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b951ed84b334332afdc952be95c34f9

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X,1465-9921

DOI

10.1186/s12931-017-0556-3

How to access this item